Abstract:We read, with great interest, the article by Sookoian et al. reporting on when after having performed a systematic review by a meta-analysis, they found that the I148M variant of PNPLA3 can be used as a risk marker for predicting susceptibility and histological severity of nonalcoholic fatty liver disease (NAFLD).1 Here, we would like to draw attention to our similar studies between rs738409 in PNPLA3 and NAFLD in the Chinese population and that we found significant associations between rs738409 and NAFLD. Recent genome-wide association studies revealed that the genetic variation, rs738409 (I148M), in PNPLA3 influences NAFLD and plasma levels of liver enzymes.2-4 However, the association of rs738409 with the development and severity of NAFLD in the Chinese population has not yet been reported. We tested the association of histologic NAFLD with the I148M variant of PNPLA3 in 112 patients of NAFLD and 120 matched controls in our department. Our results showed that in the Chinese population, individuals harboring the G allele of rs738409 were susceptible to NAFLD, and that rs738409 was associated with the histological fibrosis stage. PNPLA3 may be involved in the progression of fibrosis in NAFLD. Our results showed that the rs738409 G allele in PNPLA3 was significantly associated with increased odds of histologic NAFLD (odds ratio [OR] = 3.03; 95% confidence interval [CI] = 1.98-6.71). After analysis of the association between the G allele of rs738409 in PNPLA3 and the steatosis grade, we found that there was not an association (P > 0.05). Furthermore, we also did not observe any association of this variant with body mass index, triglyceride levels, high- and low-density lipoprotein levels, or diabetes (P > 0.05). Generally, our research results are very similar to Prof. Sookoian's previous report. In summary, our data highlight three points. First, we show that genetic variation at PNPLA3 confers a markedly increased risk of increasingly severe histological features of NAFLD, not only limited to European populations. Second, our research sample size is small and only a single central research, and this did not allow us to get the better results, compared with Prof. Sookoian's report. Third, although the genotypes of different geographic and ethnic factors may have a significant effect on the above results, we still want to say that the I148M variant of PNPLA3 can be used as a risk marker for predicting the susceptibility and histological severity of NAFLD in the Chinese population. Xiaohua Li Ph.D., M.D.*, Qingchuan Zhao Ph.D. M.D.*, Kaichun Wu Ph.D., M.D.*, Daiming Fan Ph.D., M.D.*, * Xijing Hospital of Digestive Disease, Xi'an, China.

PNPLA3 Rs738409 Underlies Treatment Response in Nonalcoholic Fatty Liver Disease

PNPLA3 Rs139051 is Associated with Phospholipid Metabolite Profile and Hepatic Inflammation in Nonalcoholic Fatty Liver Disease

Polymorphism Rs738409 in PNPLA3 is Associated with Inherited Susceptibility to Non-Alcoholic Fatty Liver Disease

Association Between PNPLA3 Rs738409 Polymorphism and Nonalcoholic Fatty Liver Disease (NAFLD) Susceptibility and Severity

PNPLA3 as a therapeutic target for fatty liver disease: the evidence to date

I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders

Patatin-like Phospholipase Domain-Containing 3 Gene (PNPLA3) Polymorphic (rs738409) Single Nucleotide Polymorphisms and Susceptibility to Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Twenty Studies

Association between patatin-like phospholipase domain-containing protein 3 gene rs738409 polymorphism and non-alcoholic fatty liver disease susceptibility: a Meta-analysis

PNPLA3 I148M Variant Affects Non-Alcoholic Fatty Liver Disease in Liver Transplant Recipients

PNPLA 3 I 148 M Variant in Nonalcoholic Fatty Liver Disease : Demographic and Ethnic Characteristics and the Role of the Variant in Nonalcoholic Fatty Liver Fibrosis

Genetic Variation in PNPLA3 Confers Susceptibility to Nonalcoholic Fatty Liver Disease

The PNPLA3 rs738409 C>G variant interacts with changes in body weight over time to aggravate liver steatosis, but reduces the risk of incident type 2 diabetes

Association of patatin-like phospholipase domain-containing protein 3 gene polymorphisms with susceptibility of nonalcoholic fatty liver disease in a Han Chinese population.

The rs2294918 E434K variant modulates PNPLA3 expression and liver damage.

I148M Variant of PNPLA3 Confer Increased Risk for Nonalcoholic Fatty Liver Disease Not Only in European Population, but Also in Chinese Population

A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease

Associations of PNPLA3 Rs738409 Polymorphism with Plasma Lipid Levels: A Systematic Review and Meta-Analysis

Linked PNPLA3 polymorphisms confer susceptibility to nonalcoholic steatohepatitis and decreased viral load in chronic hepatitis B.

PNPLA3 gene-by-visceral adipose tissue volume interaction and the pathogenesis of fatty liver disease: The NHLBI Family Heart Study

Hepatic patatin‐like phospholipase domain‐containing 3 levels are increased in I148M risk allele carriers and correlate with NAFLD in humans

PNPLA3 Rs738409 is Associated with Renal Glomerular and Tubular Injury in NAFLD Patients with Persistently Normal ALT Levels